You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu

News

First adrenal insufficiency patient dosed in Phase II study

Diurnal has announced that the first patient has been dosed in its phase 2 European clinical trial of modified-release hydrocortisone.